KATIE HODGES: Open Payments
NPI 1760853923 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,882 in 107 payments from 20 companies in 2025. Trend: 2023 $2,310 · 2024 $2,616 · 2025 $2,882
Food & beverage: $2,666Education: $216
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $550 |
| Janssen Biotech, Inc. | 14 | $537 |
| GENZYME CORPORATION | 7 | $317 |
| UCB, Inc. | 14 | $231 |
| ABBVIE INC. | 13 | $225 |
| Novartis Pharmaceuticals Corporation | 10 | $199 |
| PFIZER INC. | 5 | $182 |
| Regeneron Healthcare Solutions, Inc. | 5 | $161 |
| Organon LLC | 5 | $85 |
| Lilly USA, LLC | 3 | $61 |
Products named: TREMFYA, DUPIXENT, ILUMYA, Bimzelx, Leqselvi, LITFULO, RINVOQ, SKYRIZI.
Industry payments across MD — which companies pay providers there.
